Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased occurrence of foetal damage. The safety of benzydamine hydrochloride has not been established in pregnant and lactating patients. Risk to benefit ratio should be established if Difflam Anti-Inflammatory Lozenges (with Antibacterial) are to be used in these patients.